2019 IPO

Atreca Stock

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Sign up today and learn more about Atreca Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Atreca Stock

Atreca is a biopharmaceutical company whose Immune Repertoire Capture™ technology revolutionizes the discovery and development of a wide range of products.

Funding History

October 2011$160K
September 2012$6.0M
August 2013$700K
November 2015$56.0M
August 2017$35.0M
September 2018$125M


Co-Founder , Senior Vice President & Corporate Development

Paulette Dillon

Co-founder , Vice President & Research

Daniel Emerling

Co-Founder & Chief Technologist

Yann Chong Tan

Co-Founder , President, CEO & Chief Scientific Officer

Tito A Serafini

Co-founder & CTO

Guy Cavet

Co-founder , Vice President, Informatics and Information Technology

Wayne Volkmuth

Co-founder , Vice President, Finance and Operations

Jonathan Woo

Chief Scientific Officer and Senior Vice President

Norman Greenberg

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: